News
Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar
Digest more
Novo Nordisk shares plunge
Digest more
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Novo Nordisk (NVO) is on pace to gap lower at the opening bell today, with shares of the pharma giant plunging up to 30% in ...
Pharma giant Novo Nordisk A/S (NYSE:NVO) is plunging 21% to trade at a nearly three-year low of $54.27, after the company's ...
The U.S. FDA ban on compounded versions of Novo Nordisk's Wegovy has increased its prescriptions by 33%. Despite this, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback